Molbio Diagnostics IPO entered its final bidding day with strong demand, with the Rs 939.70-crore issue subscribed 4.91 times. Its GMP has risen to 17.1%, signalling expectations of a strong listing. The IPO comprises a Rs 200-crore fresh issue and a Rs 739.70-crore OFS.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.